Shingrix vial kits
Ended Awarded
- Contract number
- SPE2DB25FWKJX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,278
Award facts
- Contract value 100% obligated
- $2,278.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,278.36 to AmerisourceBergen Drug Corp for Shingrix vial kits on September 2, 2025, with an ultimate completion date of September 3, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine used for the prevention of herpes zoster (shingles) and is a critical pharmaceutical supply for military and veteran healthcare systems managed through DLA's medical supply chain.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including vaccines, specialty medications, and other critical medical commodities. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated its capability to fulfill federal medical procurement requirements through consistent competitive awards across multiple therapeutic domains and delivery models.
Quick answers
Who was awarded contract SPE2DB25FWKJX?
SPE2DB25FWKJX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 2, 2025.
How much is contract SPE2DB25FWKJX worth?
The government has obligated $2,278 on SPE2DB25FWKJX.
Is contract SPE2DB25FWKJX an order under another contract?
Yes. SPE2DB25FWKJX is a delivery order under SPE2DB25D3020, an indefinite delivery contract.
Was contract SPE2DB25FWKJX competed?
The extent of competition for SPE2DB25FWKJX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award